# Tompkins Financial Corp: financial statements, quarterly

TMP · NYSE · CIK 1005817 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tmp.md) · [Financials](/companies/tmp/financials.md) · [Filings](/companies/tmp/filings.md) · [Insiders](/companies/tmp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tmp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.7](/filings/0001005817-24-000027.md) | [17.2 d](/filings/0001005817-26-000027.md) | [20.3](/filings/0001005817-25-000117.md) | [19.3](/filings/0001005817-24-000022.md) | [21.3](/filings/0001005817-24-000027.md) | [18.5 d](/filings/0001005817-26-000027.md) | [21.5](/filings/0001005817-25-000117.md) | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [24.5](/filings/0001005817-24-000027.md) | [28.4 d](/filings/0001005817-24-000008.md) | [32.5](/filings/0001005817-24-000014.md) | [34.3](/filings/0001005817-24-000022.md) | [35.9](/filings/0001005817-24-000027.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(8.3)](/filings/0001005817-24-000027.md) | [3.1 d](/filings/0001005817-26-000027.md) | [5.2](/filings/0001005817-25-000117.md) | [4.9](/filings/0001005817-25-000110.md) | [5.9](/filings/0001005817-25-000115.md) | [6.0 d](/filings/0001005817-26-000027.md) | [6.1](/filings/0001005817-26-000049.md) | [6.8](/filings/0001005817-26-000112.md) | [7.4](/filings/0001005817-25-000115.md) | [43.5 d](/filings/0001005817-26-000027.md) | [8.4](/filings/0001005817-26-000049.md) | [9.2](/filings/0001005817-26-000112.md) |
| Net income | $m | [(33.4)](/filings/0001005817-24-000027.md) | [15.0 d](/filings/0001005817-26-000027.md) | [16.9](/filings/0001005817-25-000117.md) | [15.7](/filings/0001005817-25-000110.md) | [18.6](/filings/0001005817-25-000115.md) | [19.7 d](/filings/0001005817-26-000027.md) | [19.7](/filings/0001005817-26-000049.md) | [21.5](/filings/0001005817-26-000112.md) | [23.7](/filings/0001005817-25-000115.md) | [96.2 d](/filings/0001005817-26-000027.md) | [26.1](/filings/0001005817-26-000049.md) | [29.3](/filings/0001005817-26-000112.md) |
| Diluted EPS | $ per share | [(2.35)](/filings/0001005817-24-000027.md) | not reported | [1.18](/filings/0001005817-25-000117.md) | [1.10](/filings/0001005817-25-000110.md) | [1.30](/filings/0001005817-25-000115.md) | not reported | [1.37](/filings/0001005817-26-000049.md) | [1.50](/filings/0001005817-26-000112.md) | [1.65](/filings/0001005817-25-000115.md) | not reported | [1.82](/filings/0001005817-26-000049.md) | [2.04](/filings/0001005817-26-000112.md) |
| Basic EPS | $ per share | [(2.35)](/filings/0001005817-24-000027.md) | not reported | [1.19](/filings/0001005817-25-000117.md) | [1.10](/filings/0001005817-25-000110.md) | [1.31](/filings/0001005817-25-000115.md) | not reported | [1.38](/filings/0001005817-26-000049.md) | [1.51](/filings/0001005817-26-000112.md) | [1.66](/filings/0001005817-25-000115.md) | not reported | [1.83](/filings/0001005817-26-000049.md) | [2.06](/filings/0001005817-26-000112.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [140](/filings/0001005817-23-000014.md) | [79.5](/filings/0001005817-25-000006.md) | [57.1](/filings/0001005817-24-000014.md) | [70.9](/filings/0001005817-24-000022.md) | [132](/filings/0001005817-24-000027.md) | [134](/filings/0001005817-26-000027.md) | [193](/filings/0001005817-25-000117.md) | [213](/filings/0001005817-25-000110.md) | [193](/filings/0001005817-25-000115.md) | [133](/filings/0001005817-26-000112.md) | [171](/filings/0001005817-26-000049.md) | [148](/filings/0001005817-26-000112.md) |
| Total assets | $m | [7,691](/filings/0001005817-24-000027.md) | [7,820](/filings/0001005817-26-000027.md) | [7,778](/filings/0001005817-25-000117.md) | [7,870](/filings/0001005817-25-000110.md) | [8,006](/filings/0001005817-25-000115.md) | [8,109](/filings/0001005817-26-000027.md) | [8,200](/filings/0001005817-26-000049.md) | [8,374](/filings/0001005817-26-000112.md) | [8,469](/filings/0001005817-25-000115.md) | [8,668](/filings/0001005817-26-000112.md) | [8,696](/filings/0001005817-26-000049.md) | [8,802](/filings/0001005817-26-000112.md) |
| Total liabilities | $m | [7,079](/filings/0001005817-23-000014.md) | [7,150](/filings/0001005817-25-000006.md) | [7,109](/filings/0001005817-24-000014.md) | [7,193](/filings/0001005817-24-000022.md) | [7,285](/filings/0001005817-24-000027.md) | [7,396](/filings/0001005817-26-000027.md) | [7,458](/filings/0001005817-25-000117.md) | [7,612](/filings/0001005817-25-000110.md) | [7,680](/filings/0001005817-25-000115.md) | [7,730](/filings/0001005817-26-000112.md) | [7,749](/filings/0001005817-26-000049.md) | [7,842](/filings/0001005817-26-000112.md) |
| Shareholders' equity | $m | [611](/filings/0001005817-23-000014.md) | [669](/filings/0001005817-25-000006.md) | [668](/filings/0001005817-24-000014.md) | [675](/filings/0001005817-24-000022.md) | [720](/filings/0001005817-24-000027.md) | [713](/filings/0001005817-25-000006.md) | [741](/filings/0001005817-26-000112.md) | [762](/filings/0001005817-26-000112.md) | [789](/filings/0001005817-25-000115.md) | [938](/filings/0001005817-26-000112.md) | [947](/filings/0001005817-26-000112.md) | [960](/filings/0001005817-26-000112.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.3 d](/filings/0001005817-24-000027.md) | [18.9 d](/filings/0001005817-26-000027.md) | [23.2](/filings/0001005817-25-000117.md) | [27.3 d](/filings/0001005817-25-000110.md) | [21.2 d](/filings/0001005817-25-000115.md) | [23.2 d](/filings/0001005817-26-000027.md) | [22.2](/filings/0001005817-26-000049.md) | [18.0 d](/filings/0001005817-26-000112.md) | [35.9 d](/filings/0001005817-25-000115.md) | [(37.2) d](/filings/0001005817-26-000027.md) | [73.4](/filings/0001005817-26-000049.md) | [(15.1) d](/filings/0001005817-26-000112.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001005817-24-000027.md) | [1.5 d](/filings/0001005817-26-000027.md) | [1.4](/filings/0001005817-25-000117.md) | [1.0 d](/filings/0001005817-25-000110.md) | [2.3 d](/filings/0001005817-25-000115.md) | [1.6 d](/filings/0001005817-26-000027.md) | [1.4](/filings/0001005817-26-000049.md) | [0.7 d](/filings/0001005817-26-000112.md) | [1.0 d](/filings/0001005817-25-000115.md) | [3.9 d](/filings/0001005817-26-000027.md) | [2.3](/filings/0001005817-26-000049.md) | [2.0 d](/filings/0001005817-26-000112.md) |
| Dividends paid | $m | [8.6 d](/filings/0001005817-24-000027.md) | [8.5 d](/filings/0001005817-26-000027.md) | [8.5](/filings/0001005817-25-000117.md) | [8.7 d](/filings/0001005817-25-000110.md) | [8.7 d](/filings/0001005817-25-000115.md) | [9.1 d](/filings/0001005817-26-000027.md) | [8.8](/filings/0001005817-26-000049.md) | [8.9 d](/filings/0001005817-26-000112.md) | [8.8 d](/filings/0001005817-25-000115.md) | [9.6 d](/filings/0001005817-26-000027.md) | [9.5](/filings/0001005817-26-000049.md) | [9.6 d](/filings/0001005817-26-000112.md) |
| Share repurchases | $m | [2.3 d](/filings/0001005817-24-000027.md) | [0.0 d](/filings/0001005817-26-000027.md) | not reported | not reported | [0.0 d](/filings/0001005817-24-000027.md) | [0.0 d](/filings/0001005817-26-000027.md) | [0.0](/filings/0001005817-26-000049.md) | [0.0 d](/filings/0001005817-26-000112.md) | not reported | not reported | [1.8](/filings/0001005817-26-000049.md) | [1.0 d](/filings/0001005817-26-000112.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.4](/filings/0001005817-23-000014.md) | [14.4](/filings/0001005817-24-000014.md) | [14.3](/filings/0001005817-24-000022.md) | [14.2](/filings/0001005817-24-000027.md) | [14.2](/filings/0001005817-25-000117.md) | [14.2](/filings/0001005817-25-000110.md) | [14.3](/filings/0001005817-25-000115.md) | [14.3](/filings/0001005817-26-000049.md) | [14.3](/filings/0001005817-26-000112.md) | [14.3](/filings/0001005817-25-000115.md) | [14.3](/filings/0001005817-26-000049.md) | [14.3](/filings/0001005817-26-000112.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,382,905 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001005817-26-000112.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.